TY - JOUR
T1 - TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammation
AU - Hao, Xue
AU - Zhao, Bo
AU - Towers, Martina
AU - Liao, Liping
AU - Monteiro, Edgar Luzete
AU - Xu, Xin
AU - Freeman, Christina
AU - Peng, Hongzhuang
AU - Tang, Hsin Yao
AU - Havas, Aaron
AU - Kossenkov, Andrew V.
AU - Berger, Shelley L.
AU - Adams, Peter D.
AU - Speicher, David W.
AU - Schultz, David
AU - Marmorstein, Ronen
AU - Zaret, Kenneth S.
AU - Zhang, Rugang
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2024.
PY - 2024/2
Y1 - 2024/2
N2 - Sterile inflammation, also known as ‘inflammaging’, is a hallmark of tissue aging. Cellular senescence contributes to tissue aging, in part, through the secretion of proinflammatory factors collectively known as the senescence-associated secretory phenotype (SASP). The genetic variability of thioredoxin reductase 1 (TXNRD1) is associated with aging and age-associated phenotypes such as late-life survival, activity of daily living and physical performance in old age. TXNRD1’s role in regulating tissue aging has been attributed to its enzymatic role in cellular redox regulation. Here, we show that TXNRD1 drives the SASP and inflammaging through the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) innate immune response pathway independently of its enzymatic activity. TXNRD1 localizes to cytoplasmic chromatin fragments and interacts with cGAS in a senescence-status-dependent manner, which is necessary for the SASP. TXNRD1 enhances the enzymatic activity of cGAS. TXNRD1 is required for both the tumor-promoting and immune surveillance functions of senescent cells, which are mediated by the SASP in vivo in mouse models. Treatment of aged mice with a TXNRD1 inhibitor that disrupts its interaction with cGAS, but not with an inhibitor of its enzymatic activity alone, downregulated markers of inflammaging in several tissues. In summary, our results show that TXNRD1 promotes the SASP through the innate immune response, with implications for inflammaging. This suggests that the TXNRD1–cGAS interaction is a relevant target for selectively suppressing inflammaging.
AB - Sterile inflammation, also known as ‘inflammaging’, is a hallmark of tissue aging. Cellular senescence contributes to tissue aging, in part, through the secretion of proinflammatory factors collectively known as the senescence-associated secretory phenotype (SASP). The genetic variability of thioredoxin reductase 1 (TXNRD1) is associated with aging and age-associated phenotypes such as late-life survival, activity of daily living and physical performance in old age. TXNRD1’s role in regulating tissue aging has been attributed to its enzymatic role in cellular redox regulation. Here, we show that TXNRD1 drives the SASP and inflammaging through the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) innate immune response pathway independently of its enzymatic activity. TXNRD1 localizes to cytoplasmic chromatin fragments and interacts with cGAS in a senescence-status-dependent manner, which is necessary for the SASP. TXNRD1 enhances the enzymatic activity of cGAS. TXNRD1 is required for both the tumor-promoting and immune surveillance functions of senescent cells, which are mediated by the SASP in vivo in mouse models. Treatment of aged mice with a TXNRD1 inhibitor that disrupts its interaction with cGAS, but not with an inhibitor of its enzymatic activity alone, downregulated markers of inflammaging in several tissues. In summary, our results show that TXNRD1 promotes the SASP through the innate immune response, with implications for inflammaging. This suggests that the TXNRD1–cGAS interaction is a relevant target for selectively suppressing inflammaging.
UR - http://www.scopus.com/inward/record.url?scp=85183025153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183025153&partnerID=8YFLogxK
U2 - 10.1038/s43587-023-00564-1
DO - 10.1038/s43587-023-00564-1
M3 - Article
C2 - 38267705
AN - SCOPUS:85183025153
SN - 2662-8465
VL - 4
SP - 185
EP - 197
JO - Nature Aging
JF - Nature Aging
IS - 2
ER -